These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9089419)

  • 21. Comparison of pharmacokinetics of Neoral and Sandimmune in stable pediatric liver transplant recipients.
    van Mourik ID; Thomson M; Kelly DA
    Liver Transpl Surg; 1999 Mar; 5(2):107-11. PubMed ID: 10071349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between cyclosporine and grapefruit juice requires long-term ingestion in stable renal transplant recipients.
    Brunner LJ; Munar MY; Vallian J; Wolfson M; Stennett DJ; Meyer MM; Bennett WM
    Pharmacotherapy; 1998; 18(1):23-9. PubMed ID: 9469677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal blood concentration of cyclosporine among Iranian kidney transplant recipients.
    Rostami Z; Einollahi B; Morshedi J; Teimoori M
    Iran J Kidney Dis; 2012 Sep; 6(5):373-9. PubMed ID: 22976264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of cyclosporine malabsorption in diabetic recipients of simultaneous pancreas and kidney transplant using a microemulsion formulation.
    Chapman JR; O'Connell PJ; Bovington KJ; Allen RD
    Transplantation; 1996 Jun; 61(12):1699-704. PubMed ID: 8685946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of mycophenolic acid in children with clinically stable idiopathic nephrotic syndrome receiving cyclosporine.
    Hibino S; Nagai T; Yamakawa S; Ito H; Tanaka K; Uemura O
    Clin Exp Nephrol; 2017 Feb; 21(1):152-158. PubMed ID: 27105859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glipizide treatment of post-transplant diabetes does not interfere with cyclosporine pharmacokinetics in renal allograft recipients.
    Sagedal S; Asberg A; Hartmann A; Bergan S; Berg KJ
    Clin Transplant; 1998 Dec; 12(6):553-6. PubMed ID: 9850449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of pravastatin in heart-transplant patients taking cyclosporin A.
    Park JW; Siekmeier R; Merz M; Krell B; Harder S; März W; Seidel D; Schüler S; Gross W
    Int J Clin Pharmacol Ther; 2002 Oct; 40(10):439-50. PubMed ID: 12395976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genes.
    Hesselink DA; van Gelder T; van Schaik RH; Balk AH; van der Heiden IP; van Dam T; van der Werf M; Weimar W; Mathot RA
    Clin Pharmacol Ther; 2004 Dec; 76(6):545-56. PubMed ID: 15592326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses.
    Olbricht C; Wanner C; Eisenhauer T; Kliem V; Doll R; Boddaert M; O'Grady P; Krekler M; Mangold B; Christians U
    Clin Pharmacol Ther; 1997 Sep; 62(3):311-21. PubMed ID: 9333107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of prednisolone during administration of sirolimus in patients with renal transplants.
    Jusko WJ; Ferron GM; Mis SM; Kahan BD; Zimmerman JJ
    J Clin Pharmacol; 1996 Dec; 36(12):1100-6. PubMed ID: 9013365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of CYP3A4*1B and CYP3A5*3 polymorphisms on the pharmacokinetics of cyclosporine and sirolimus in renal transplant recipients.
    Żochowska D; Wyzgał J; Pączek L
    Ann Transplant; 2012; 17(3):36-44. PubMed ID: 23018254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporine disposition and long-term renal function in a 500-pound kidney transplant recipient.
    Flechner SM; Haug M; Fisher RK; Modlin CS
    Am J Kidney Dis; 1998 Oct; 32(4):E4. PubMed ID: 10074590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic profile of cyclosporine A after conversion to Sandimmun Optoral: influence on ambulatory blood pressure in renal transplant patients.
    Schwertfeger E; Keller E; Grotz W; Schollmeyer P; Rump LC
    Clin Nephrol; 1996 May; 45(5):349-51. PubMed ID: 8738670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of neoral dose monitoring with cyclosporine through levels versus 2-hr postdose levels in stable liver transplant patients.
    Cantarovich M; Barkun JS; Tchervenkov JI; Besner JG; Aspeslet L; Metrakos P
    Transplantation; 1998 Dec; 66(12):1621-7. PubMed ID: 9884249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced intrapatient variability of cyclosporine pharmacokinetics in renal transplant recipients switched from oral Sandimmune to Neoral.
    Mendez R; Abboud H; Burdick J; Copley B; Freeman R; Batiuk TD; Cooney GF; Barbeito R
    Clin Ther; 1999 Jan; 21(1):160-71. PubMed ID: 10090433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 50% reduction in cyclosporine exposure in stable renal transplant recipients: renal function benefits.
    Etienne I; Toupance O; Bénichou J; Thierry A; Al Najjar A; Hurault de Ligny B; Le Meur Y; Westeel PF; Marquet P; François A; Hellot MF; Godin M
    Nephrol Dial Transplant; 2010 Sep; 25(9):3096-106. PubMed ID: 20299336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two-hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy.
    Cantarovich M; Besner JG; Barkun JS; Elstein E; Loertscher R
    Clin Transplant; 1998 Jun; 12(3):243-9. PubMed ID: 9642517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic drug monitoring of cyclosporine and area under the curve prediction using a single time point strategy: appraisal using peak concentration data.
    Srinivas NR
    Biopharm Drug Dispos; 2015 Dec; 36(9):575-86. PubMed ID: 26224332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus.
    Hesselink DA; van Schaik RH; van der Heiden IP; van der Werf M; Gregoor PJ; Lindemans J; Weimar W; van Gelder T
    Clin Pharmacol Ther; 2003 Sep; 74(3):245-54. PubMed ID: 12966368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine.
    Flechner SM; Goldfarb D; Modlin C; Feng J; Krishnamurthi V; Mastroianni B; Savas K; Cook DJ; Novick AC
    Transplantation; 2002 Oct; 74(8):1070-6. PubMed ID: 12438948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.